Tags: U.S., sickle cell disease, regulators, First Crispr Gene-Editing Drug, US, Sickle-Cell Disease, treatment, gene therapies, CRISPR gene-editing, FDA Approves World, Casgevy,

Help Keep This Site Alive
I built and maintain this site on my own, but rising hosting costs are becoming unsustainable. Your donation would help cover costs and allow me to focus on improving the site.